Effectiveness of text message based, diabetes self management support programme (SMS4BG): two arm, parallel randomised controlled trial

BMJ : British Medical Journal
Rosie DobsonRinki Murphy

Abstract

To determine the effectiveness of a theoretically based and individually tailored, text message based, diabetes self management support intervention (SMS4BG) in adults with poorly controlled diabetes. Nine month, two arm, parallel randomised controlled trial. Primary and secondary healthcare services in New Zealand. 366 participants aged 16 years and over with poorly controlled type 1 or type 2 diabetes (HbA1c ≥65 mmol/mol or 8%) randomised between June 2015 and November 2016 (n=183 intervention, n=183 control). The intervention group received a tailored package of text messages for up to nine months in addition to usual care. Text messages provided information, support, motivation, and reminders related to diabetes self management and lifestyle behaviours. The control group received usual care. Messages were delivered by a specifically designed automated content management system. Primary outcome measure was change in glycaemic control (HbA1c) from baseline to nine months. Secondary outcomes included change in HbA1c at three and six months, and self efficacy, diabetes self care behaviours, diabetes distress, perceptions and beliefs about diabetes, health related quality of life, perceived support for diabetes management, and i...Continue Reading

Citations

Aug 24, 2018·Drug and Therapeutics Bulletin
Nov 14, 2019·Diabetic Medicine : a Journal of the British Diabetic Association·R DobsonR Murphy
Apr 10, 2019·Journal of Medical Internet Research·Allison A LewinskiHayden B Bosworth
Nov 7, 2019·Diabetes Technology & Therapeutics·Christopher G ParkinRolf Hinzmann
Mar 19, 2019·Exercise and Sport Sciences Reviews·Ralph MaddisonClara K Chow
Mar 18, 2020·BMJ : British Medical Journal·Laura MartinengoJosip Car
Dec 21, 2019·Journal of Medical Internet Research·Jane C WillcoxRobyn Whittaker
Jul 22, 2019·JMIR Human Factors·Patricia Grace-Farfaglia
Nov 10, 2020·Journal of the American Medical Informatics Association : JAMIA·Christina HigaJoanne R Loos
Dec 12, 2020·Diabetic Medicine : a Journal of the British Diabetic Association·Mohsen AlyamiElizabeth Broadbent
Jan 20, 2021·Trials·Bettina PetersenLutz Heinemann
Dec 17, 2020·BMC Medicine·Paul LoubetDidier Laureillard
Aug 21, 2021·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Wenwen YangZihan Geng
Aug 23, 2021·BMC Medical Research Methodology·Sina KianersiMolly Rosenberg

❮ Previous
Next ❯

Software Mentioned

REDCap
SAS
SMS4BG

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.